Munafa Stock Market Course + Intraday & FNO calls 
Nektar Therapeutics (NKTR) Technical (Analysis) Reports Nektar Therapeutics ["Technical Analysis"] Reports -USA Stock Exchange MunafaSutra.com
Complete & easy to understand technical analysis of Nektar Therapeutics (NKTR)
Technical Analysis Report for USA stock NKTR Nektar Therapeutics. Dated: 25 Sep 2026 Updated Daily. Stock trades under Health Care Deals in Major Pharmaceuticals in USA stock exchange
If you are looking for Tomorrow's Movement Predictions for USA stock NKTR Nektar Therapeutics then click here. or read Experts views on Nektar Therapeutics or Forecast & share price targets of Nektar Therapeutics
Nektar Therapeutics Opened at 59.77 and Closed at: 57.06, which is -3.96% of previous session's close. It moved within a range of 57.04 and 60.98
The session was a Bearish session with an average volume of 2636100, which is 43.1% of previous session's volumes.
- The stock has fallen, and its short term trend is also negative and in a downtrend.
- The stock has fallen, and its mid term trend is also negative and in a downtrend.
- There is some negative change in the long term trend, but its too soon to jump onto conclusions.
A Dead cross was found 8 days back on mid term averages
Support for tomorrow is 55.08 and resistance for tomorrow is 59.02
These support and resistance points are valid for the first 5-15 minutes charts
Above are simple pivot point calculations. For a list of much stronger support and resistance levels click here. These are way more stronger support and resistance levels, and mark trend reversals and are Support & Resistance levels recommended by experts.
Support for tomorrow's hourly charts is 55.74, 54.42 resistance for tomorrow's hourly charts is 59.68, 62.3
10 Day SMA for Nektar Therapeutics (NKTR) is 63.98 and stock is trading below these levels. This is not a good sign for its short term trend
20 Day SMA for Nektar Therapeutics (NKTR) is 68.39 and the stock is trading below these levels. This is not a good sign for its mid term trend
50 Day SMA for Nektar Therapeutics (NKTR) is 70.92 and the stock is trading below these levels. This is not a good sign for its mid to long term trend
100 Day SMA is 69.02 and the stock is trading below these levels. This is not a good sign for its long term trend
200 Day SMA Nektar Therapeutics is 65.55 and stock is trading below these levels. This is not a good sign for its long term trend
20 DMA of Nektar Therapeutics is at 68.39 and 200 DMA is at 65.55, while 50 DMA and 100 DMA are at 70.92 and 69.02 respectively
Nektar Therapeutics (NKTR) moving average of 20 SMA is at 68.39 and 20 EMA is at 66.57
| Date | Closing Price | 20 SMA | 20 EMA |
| 25 Fri Sep | 57.06 | 68.39 | 66.57 |
| 24 Thu Sep | 59.32 | 69.27 | 67.57 |
| 23 Wed Sep | 57.66 | 69.99 | 68.44 |
| 22 Tue Sep | 60.97 | 70.86 | 69.57 |
| 21 Mon Sep | 66.84 | 71.49 | 70.48 |
| 18 Fri Sep | 67.10 | 71.85 | 70.86 |
Nektar Therapeutics (NKTR) moving average of 50 SMA is at 70.92 and 50 EMA is at 69.24
| Date | Closing Price | 50 SMA | 50 EMA |
| 25 Fri Sep | 57.06 | 70.92 | 69.24 |
| 24 Thu Sep | 59.32 | 71.14 | 69.74 |
| 23 Wed Sep | 57.66 | 71.3 | 70.17 |
| 22 Tue Sep | 60.97 | 71.51 | 70.68 |
| 21 Mon Sep | 66.84 | 71.64 | 71.08 |
| 18 Fri Sep | 67.10 | 71.66 | 71.25 |
Nektar Therapeutics (NKTR) moving average of 100 SMA is at 69.02 and 100 EMA is at 69.12
| Date | Closing Price | 100 SMA | 100 EMA |
| 25 Fri Sep | 57.06 | 69.02 | 69.12 |
| 24 Thu Sep | 59.32 | 69.3 | 69.36 |
| 23 Wed Sep | 57.66 | 69.54 | 69.56 |
| 22 Tue Sep | 60.97 | 69.84 | 69.8 |
| 21 Mon Sep | 66.84 | 70.09 | 69.98 |
| 18 Fri Sep | 67.10 | 70.27 | 70.04 |
Nektar Therapeutics (NKTR) moving average of 200 SMA is at 65.55 and 200 EMA is at 62.94
| Date | Closing Price | 200 SMA | 200 EMA |
| 25 Fri Sep | 57.06 | 65.55 | 62.94 |
| 24 Thu Sep | 59.32 | 65.56 | 63 |
| 23 Wed Sep | 57.66 | 65.55 | 63.04 |
| 22 Tue Sep | 60.97 | 65.55 | 63.09 |
| 21 Mon Sep | 66.84 | 65.53 | 63.11 |
| 18 Fri Sep | 67.10 | 65.48 | 63.07 |
Stryker Corporation has performed better than Nektar Therapeutics in short term. You could have earned much better returns by investing in Stryker Corporation, about 3.68% more returns!
Pfizer Inc has performed better than Nektar Therapeutics in short term. You could have earned much better returns by investing in Pfizer Inc, about 23.93% more returns!
Medtronic Plc has performed better than Nektar Therapeutics in short term. You could have earned much better returns by investing in Medtronic Plc, about 18.47% more returns!
Utah Medical has performed better than Nektar Therapeutics in short term. You could have earned much better returns by investing in Utah Medical, about 23.26% more returns!
Nektar Therapeutics has performed better than Tandem Diabetes in short term. Holding Nektar Therapeutics could be a better choice for now!
Rhythm Pharmaceuticals has performed better than Nektar Therapeutics in short term. You could have earned much better returns by investing in Rhythm Pharmaceuticals, about 13.38% more returns!
Replimune Group has performed better than Nektar Therapeutics in short term. You could have earned much better returns by investing in Replimune Group, about 1.06% more returns!
Lipocine Inc has performed better than Nektar Therapeutics in short term. You could have earned much better returns by investing in Lipocine Inc, about 18.09% more returns!
Livanova Plc has performed better than Nektar Therapeutics in short term. You could have earned much better returns by investing in Livanova Plc, about 16.73% more returns!
Integra Lifesciences has performed better than Nektar Therapeutics in short term. You could have earned much better returns by investing in Integra Lifesciences, about 16.76% more returns!
Healthcare Services has performed better than Nektar Therapeutics in short term. You could have earned much better returns by investing in Healthcare Services, about 15.13% more returns!
Galectin Therapeutics has performed better than Nektar Therapeutics in short term. You could have earned much better returns by investing in Galectin Therapeutics, about 18.33% more returns!
Corvus Pharmaceuticals has performed better than Nektar Therapeutics in short term. You could have earned much better returns by investing in Corvus Pharmaceuticals, about 3.38% more returns!
Anavex Life has performed better than Nektar Therapeutics in short term. You could have earned much better returns by investing in Anavex Life, about 0.92% more returns!
Nektar Therapeutics has performed better than Assembly Biosciences in short term. Holding Nektar Therapeutics could be a better choice for now!
Altimmune Inc has performed better than Nektar Therapeutics in short term. You could have earned much better returns by investing in Altimmune Inc, about 20.03% more returns!
Align Technology has performed better than Nektar Therapeutics in short term. You could have earned much better returns by investing in Align Technology, about 14.47% more returns!
Agios Pharmaceuticals has performed better than Nektar Therapeutics in short term. You could have earned much better returns by investing in Agios Pharmaceuticals, about 19.1% more returns!
Nektar Therapeutics Technical analysis of indicators
Price action analysis of Nektar Therapeutics (NKTR) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Nektar Therapeutics stock for short term is SELL. Signal strength is Strong and stock is gaining momentum.
MACD generated a SELL signal for Nektar Therapeutics in short term and the sell signal is strong.
Nektar Therapeutics Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are getting stronger in this stock.
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be coming down
CCI has generated a SELL signal for Nektar Therapeutics in short term and SELL signal is strong!
RSI is generating a SELL signal in short term and selling is picking up momentum.
MRSI is in negative zone. This is the SELL zone
Although the stock is in the SELL zone, but selling might be slowing down
Stock of Nektar Therapeutics is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 62.64 and Nektar Therapeutics NKTR stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Nektar Therapeutics NKTR stock. Volume based technical analysis of Nektar Therapeutics NKTR stock is negative.
Nektar Therapeutics Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Tomorrow's Predictions
You should also read Tomorrow's Movement Predictions for USA stock NKTR Nektar Therapeutics These predictions are based on various factors, are easy to understand, and upto 75% accurate!
And NKTR Experts View which covers a lot of information including buying and selling signals
NKTR future forecast & share price targets
You can also take a look at the Charts and indicator analysis here Announcements & NEWS by Nektar Therapeutics or View Candle Stick Charts here
Quick Charts: Renko Point & Figure Just IntraDay All Indicators Weekly Monthly All in One Eagle View MACD & ADX
Videos related to: Nektar Therapeutics (NKTR) Technical (Analysis) Reports Nektar Therapeutics ["Technical Analysis"] Reports -USA Stock Exchange MunafaSutra.com
Hindi Video Correct Way Of Technical Analysis How To Find Entry Exit Points On Charts
Hindi Video Most Important Stock Market Video. No Success Without This Formula
- USA Screeners
- USA Daily Screener
- USA Weekly Screener
- USA Monthly Screener
- Support & Resistance
- USA Shares Near Support
- USA Shares Near Resistance
